News & Events
-
Partnership blends artificial intelligence (AI) tools with clinical data and research practices.Learn about a collaboration between NCI and a company that develops AI-powered solutions for cancer diagnostics and therapeutics to make greater inroads into personalized treatment for cancer patients.
-
Partnership Resulting in Commercialization of axicabtagene ciloleucelDr. Steven Rosenberg shares the story of the development and commercialization of a highly personalized CAR T-cell immunotherapy for the treatment of cancer.
-
Learn about the new Start-Up 3.0 LicenseThe NCI Start-Up Exclusive License is for early and R&D stage companies developing early-stage therapeutic, vaccine, device, and certain diagnostic technologies.
-
Available Technologies
-
Prospective Partners
-
NIH Investigators
Explore Fellowships at TTC
Develop and enhance your lab-to-market skills to advance your career. The Technology Transfer Center offers a variety of full time and fully paid fellowship opportunities available to post-graduate trainees.
Learn More
Partnering with NIH to Bring Innovations to Market